,,Hummm,,,,I am scratching my head as to why any company would refrain from proving trial data when it is available. I can see if patents are not established or if some other competition factor was involved. But other than that if RVX has confirmed data of material value, good or bad, why it would not be released when top line results are announced. Is there a competitive edge lost somehow? Do we still have access to this 3rd party technology for analyzing trial data and is this technology going to be used to assess our results on BoM? ,,again,,its just me having too much time to think here.